Compile Data Set for Download or QSAR
Report error Found 80 Enz. Inhib. hit(s) with all data for entry = 11512
TargetPlatelet-derived growth factor receptor beta(Human)
Wenzhou Medical University

US Patent
LigandPNGBDBM50604027(CHEMBL5184634 | US20230312529, Compound 6i)
Affinity DataIC50: 1.70nMAssay Description:The method adopted in the test was Caliper Mobility Shift Assay, which was a detection platform based on the mobility detection technology of microfl...More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/13/2023
Entry Details
Go to US Patent

TargetPlatelet-derived growth factor receptor beta(Human)
Wenzhou Medical University

US Patent
LigandPNGBDBM50604027(CHEMBL5184634 | US20230312529, Compound 6i)
Affinity DataIC50: 1.70nMAssay Description:The method adopted in the test was Caliper Mobility Shift Assay, which was a detection platform based on the mobility detection technology of microfl...More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/13/2023
Entry Details
Go to US Patent

TargetPlatelet-derived growth factor receptor beta(Human)
Wenzhou Medical University

US Patent
LigandPNGBDBM50604028(CHEMBL5173185 | US20230312529, Compound 6f)
Affinity DataIC50: 2.60nMAssay Description:The method adopted in the test was Caliper Mobility Shift Assay, which was a detection platform based on the mobility detection technology of microfl...More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/13/2023
Entry Details
Go to US Patent

TargetPlatelet-derived growth factor receptor beta(Human)
Wenzhou Medical University

US Patent
LigandPNGBDBM50604028(CHEMBL5173185 | US20230312529, Compound 6f)
Affinity DataIC50: 2.60nMAssay Description:The method adopted in the test was Caliper Mobility Shift Assay, which was a detection platform based on the mobility detection technology of microfl...More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/13/2023
Entry Details
Go to US Patent

TargetPlatelet-derived growth factor receptor alpha(Human)
Wenzhou Medical University

US Patent
LigandPNGBDBM50604027(CHEMBL5184634 | US20230312529, Compound 6i)
Affinity DataIC50: 2.70nMAssay Description:The method adopted in the test was Caliper Mobility Shift Assay, which was a detection platform based on the mobility detection technology of microfl...More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/13/2023
Entry Details
Go to US Patent

TargetPlatelet-derived growth factor receptor alpha(Human)
Wenzhou Medical University

US Patent
LigandPNGBDBM50604027(CHEMBL5184634 | US20230312529, Compound 6i)
Affinity DataIC50: 2.70nMAssay Description:The method adopted in the test was Caliper Mobility Shift Assay, which was a detection platform based on the mobility detection technology of microfl...More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/13/2023
Entry Details
Go to US Patent

TargetPlatelet-derived growth factor receptor beta(Human)
Wenzhou Medical University

US Patent
LigandPNGBDBM50604029(CHEMBL5176371 | US20230312529, Compound 6a)
Affinity DataIC50: 4.20nMAssay Description:The method adopted in the test was Caliper Mobility Shift Assay, which was a detection platform based on the mobility detection technology of microfl...More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/13/2023
Entry Details
Go to US Patent

TargetALK tyrosine kinase receptor(Human)
Wenzhou Medical University

US Patent
LigandPNGBDBM50604027(CHEMBL5184634 | US20230312529, Compound 6i)
Affinity DataIC50: 5nMAssay Description:The method adopted in the test was Caliper Mobility Shift Assay, which was a detection platform based on the mobility detection technology of microfl...More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/13/2023
Entry Details
Go to US Patent

TargetALK tyrosine kinase receptor(Human)
Wenzhou Medical University

US Patent
LigandPNGBDBM50604036(CHEMBL5190005 | US20230312529, Compound 6h)
Affinity DataIC50: 5.80nMAssay Description:The method adopted in the test was Caliper Mobility Shift Assay, which was a detection platform based on the mobility detection technology of microfl...More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/13/2023
Entry Details
Go to US Patent

TargetTyrosine-protein kinase JAK1(Human)
Wenzhou Medical University

US Patent
LigandPNGBDBM50604030(CHEMBL5206707 | US20230312529, Compound 6n)
Affinity DataIC50: 6nMAssay Description:The method adopted in the test was Caliper Mobility Shift Assay, which was a detection platform based on the mobility detection technology of microfl...More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/13/2023
Entry Details
Go to US Patent

TargetALK tyrosine kinase receptor(Human)
Wenzhou Medical University

US Patent
LigandPNGBDBM50604037(CHEMBL5183593 | US20230312529, Compound 6e)
Affinity DataIC50: 7nMAssay Description:The method adopted in the test was Caliper Mobility Shift Assay, which was a detection platform based on the mobility detection technology of microfl...More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/13/2023
Entry Details
Go to US Patent

TargetPlatelet-derived growth factor receptor beta(Human)
Wenzhou Medical University

US Patent
LigandPNGBDBM621802(US20230312529, Compound 5k)
Affinity DataIC50: 7.30nMAssay Description:The method adopted in the test was Caliper Mobility Shift Assay, which was a detection platform based on the mobility detection technology of microfl...More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/13/2023
Entry Details
Go to US Patent

TargetPlatelet-derived growth factor receptor alpha(Human)
Wenzhou Medical University

US Patent
LigandPNGBDBM50604028(CHEMBL5173185 | US20230312529, Compound 6f)
Affinity DataIC50: 7.40nMAssay Description:The method adopted in the test was Caliper Mobility Shift Assay, which was a detection platform based on the mobility detection technology of microfl...More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/13/2023
Entry Details
Go to US Patent

TargetPlatelet-derived growth factor receptor alpha(Human)
Wenzhou Medical University

US Patent
LigandPNGBDBM50604028(CHEMBL5173185 | US20230312529, Compound 6f)
Affinity DataIC50: 7.40nMAssay Description:The method adopted in the test was Caliper Mobility Shift Assay, which was a detection platform based on the mobility detection technology of microfl...More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/13/2023
Entry Details
Go to US Patent

TargetTyrosine-protein kinase JAK1(Human)
Wenzhou Medical University

US Patent
LigandPNGBDBM50604027(CHEMBL5184634 | US20230312529, Compound 6i)
Affinity DataIC50: 7.70nMAssay Description:The method adopted in the test was Caliper Mobility Shift Assay, which was a detection platform based on the mobility detection technology of microfl...More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/13/2023
Entry Details
Go to US Patent

TargetPlatelet-derived growth factor receptor beta(Human)
Wenzhou Medical University

US Patent
LigandPNGBDBM621973(US20230312529, Compound 5i)
Affinity DataIC50: 7.90nMAssay Description:The method adopted in the test was Caliper Mobility Shift Assay, which was a detection platform based on the mobility detection technology of microfl...More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/13/2023
Entry Details
Go to US Patent

TargetPlatelet-derived growth factor receptor beta(Human)
Wenzhou Medical University

US Patent
LigandPNGBDBM50604031(CHEMBL5208704 | US20230312529, Compound 6g)
Affinity DataIC50: 8.80nMAssay Description:The method adopted in the test was Caliper Mobility Shift Assay, which was a detection platform based on the mobility detection technology of microfl...More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/13/2023
Entry Details
Go to US Patent

TargetPlatelet-derived growth factor receptor beta(Human)
Wenzhou Medical University

US Patent
LigandPNGBDBM50604031(CHEMBL5208704 | US20230312529, Compound 6g)
Affinity DataIC50: 8.80nMAssay Description:The method adopted in the test was Caliper Mobility Shift Assay, which was a detection platform based on the mobility detection technology of microfl...More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/13/2023
Entry Details
Go to US Patent

TargetALK tyrosine kinase receptor(Human)
Wenzhou Medical University

US Patent
LigandPNGBDBM50604028(CHEMBL5173185 | US20230312529, Compound 6f)
Affinity DataIC50: 11nMAssay Description:The method adopted in the test was Caliper Mobility Shift Assay, which was a detection platform based on the mobility detection technology of microfl...More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/13/2023
Entry Details
Go to US Patent

TargetPlatelet-derived growth factor receptor beta(Human)
Wenzhou Medical University

US Patent
LigandPNGBDBM50604033(CHEMBL5182087 | US20230312529, Compound 6j)
Affinity DataIC50: 12nMAssay Description:The method adopted in the test was Caliper Mobility Shift Assay, which was a detection platform based on the mobility detection technology of microfl...More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/13/2023
Entry Details
Go to US Patent

TargetPlatelet-derived growth factor receptor beta(Human)
Wenzhou Medical University

US Patent
LigandPNGBDBM50604033(CHEMBL5182087 | US20230312529, Compound 6j)
Affinity DataIC50: 12nMAssay Description:The method adopted in the test was Caliper Mobility Shift Assay, which was a detection platform based on the mobility detection technology of microfl...More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/13/2023
Entry Details
Go to US Patent

TargetTyrosine-protein kinase JAK1(Human)
Wenzhou Medical University

US Patent
LigandPNGBDBM50604031(CHEMBL5208704 | US20230312529, Compound 6g)
Affinity DataIC50: 13nMAssay Description:The method adopted in the test was Caliper Mobility Shift Assay, which was a detection platform based on the mobility detection technology of microfl...More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/13/2023
Entry Details
Go to US Patent

TargetTyrosine-protein kinase JAK1(Human)
Wenzhou Medical University

US Patent
LigandPNGBDBM50604033(CHEMBL5182087 | US20230312529, Compound 6j)
Affinity DataIC50: 14nMAssay Description:The method adopted in the test was Caliper Mobility Shift Assay, which was a detection platform based on the mobility detection technology of microfl...More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/13/2023
Entry Details
Go to US Patent

TargetPlatelet-derived growth factor receptor alpha(Human)
Wenzhou Medical University

US Patent
LigandPNGBDBM50604033(CHEMBL5182087 | US20230312529, Compound 6j)
Affinity DataIC50: 15nMAssay Description:The method adopted in the test was Caliper Mobility Shift Assay, which was a detection platform based on the mobility detection technology of microfl...More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/13/2023
Entry Details
Go to US Patent

TargetPlatelet-derived growth factor receptor alpha(Human)
Wenzhou Medical University

US Patent
LigandPNGBDBM621973(US20230312529, Compound 5i)
Affinity DataIC50: 15nMAssay Description:The method adopted in the test was Caliper Mobility Shift Assay, which was a detection platform based on the mobility detection technology of microfl...More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/13/2023
Entry Details
Go to US Patent

TargetPlatelet-derived growth factor receptor alpha(Human)
Wenzhou Medical University

US Patent
LigandPNGBDBM50604033(CHEMBL5182087 | US20230312529, Compound 6j)
Affinity DataIC50: 15nMAssay Description:The method adopted in the test was Caliper Mobility Shift Assay, which was a detection platform based on the mobility detection technology of microfl...More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/13/2023
Entry Details
Go to US Patent

TargetPlatelet-derived growth factor receptor alpha(Human)
Wenzhou Medical University

US Patent
LigandPNGBDBM50604029(CHEMBL5176371 | US20230312529, Compound 6a)
Affinity DataIC50: 17nMAssay Description:The method adopted in the test was Caliper Mobility Shift Assay, which was a detection platform based on the mobility detection technology of microfl...More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/13/2023
Entry Details
Go to US Patent

TargetPlatelet-derived growth factor receptor alpha(Human)
Wenzhou Medical University

US Patent
LigandPNGBDBM50604031(CHEMBL5208704 | US20230312529, Compound 6g)
Affinity DataIC50: 19nMAssay Description:The method adopted in the test was Caliper Mobility Shift Assay, which was a detection platform based on the mobility detection technology of microfl...More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/13/2023
Entry Details
Go to US Patent

TargetPlatelet-derived growth factor receptor beta(Human)
Wenzhou Medical University

US Patent
LigandPNGBDBM50604030(CHEMBL5206707 | US20230312529, Compound 6n)
Affinity DataIC50: 19nMAssay Description:The method adopted in the test was Caliper Mobility Shift Assay, which was a detection platform based on the mobility detection technology of microfl...More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/13/2023
Entry Details
Go to US Patent

TargetPlatelet-derived growth factor receptor beta(Human)
Wenzhou Medical University

US Patent
LigandPNGBDBM50604030(CHEMBL5206707 | US20230312529, Compound 6n)
Affinity DataIC50: 19nMAssay Description:The method adopted in the test was Caliper Mobility Shift Assay, which was a detection platform based on the mobility detection technology of microfl...More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/13/2023
Entry Details
Go to US Patent

TargetPlatelet-derived growth factor receptor alpha(Human)
Wenzhou Medical University

US Patent
LigandPNGBDBM621802(US20230312529, Compound 5k)
Affinity DataIC50: 19nMAssay Description:The method adopted in the test was Caliper Mobility Shift Assay, which was a detection platform based on the mobility detection technology of microfl...More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/13/2023
Entry Details
Go to US Patent

TargetPlatelet-derived growth factor receptor alpha(Human)
Wenzhou Medical University

US Patent
LigandPNGBDBM50604031(CHEMBL5208704 | US20230312529, Compound 6g)
Affinity DataIC50: 19nMAssay Description:The method adopted in the test was Caliper Mobility Shift Assay, which was a detection platform based on the mobility detection technology of microfl...More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/13/2023
Entry Details
Go to US Patent

TargetPlatelet-derived growth factor receptor alpha(Human)
Wenzhou Medical University

US Patent
LigandPNGBDBM50604030(CHEMBL5206707 | US20230312529, Compound 6n)
Affinity DataIC50: 20nMAssay Description:The method adopted in the test was Caliper Mobility Shift Assay, which was a detection platform based on the mobility detection technology of microfl...More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/13/2023
Entry Details
Go to US Patent

TargetPlatelet-derived growth factor receptor alpha(Human)
Wenzhou Medical University

US Patent
LigandPNGBDBM50604030(CHEMBL5206707 | US20230312529, Compound 6n)
Affinity DataIC50: 20nMAssay Description:The method adopted in the test was Caliper Mobility Shift Assay, which was a detection platform based on the mobility detection technology of microfl...More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/13/2023
Entry Details
Go to US Patent

TargetALK tyrosine kinase receptor(Human)
Wenzhou Medical University

US Patent
LigandPNGBDBM50604033(CHEMBL5182087 | US20230312529, Compound 6j)
Affinity DataIC50: 23nMAssay Description:The method adopted in the test was Caliper Mobility Shift Assay, which was a detection platform based on the mobility detection technology of microfl...More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/13/2023
Entry Details
Go to US Patent

TargetALK tyrosine kinase receptor(Human)
Wenzhou Medical University

US Patent
LigandPNGBDBM50604031(CHEMBL5208704 | US20230312529, Compound 6g)
Affinity DataIC50: 26nMAssay Description:The method adopted in the test was Caliper Mobility Shift Assay, which was a detection platform based on the mobility detection technology of microfl...More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/13/2023
Entry Details
Go to US Patent

TargetFibroblast growth factor receptor 2(Human)
Wenzhou Medical University

US Patent
LigandPNGBDBM50604027(CHEMBL5184634 | US20230312529, Compound 6i)
Affinity DataIC50: 27nMAssay Description:The method adopted in the test was Caliper Mobility Shift Assay, which was a detection platform based on the mobility detection technology of microfl...More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/13/2023
Entry Details
Go to US Patent

TargetTyrosine-protein kinase JAK1(Human)
Wenzhou Medical University

US Patent
LigandPNGBDBM50604028(CHEMBL5173185 | US20230312529, Compound 6f)
Affinity DataIC50: 31nMAssay Description:The method adopted in the test was Caliper Mobility Shift Assay, which was a detection platform based on the mobility detection technology of microfl...More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/13/2023
Entry Details
Go to US Patent

TargetPlatelet-derived growth factor receptor beta(Human)
Wenzhou Medical University

US Patent
LigandPNGBDBM50604034(CHEMBL5187885 | US20230312529, Compound 6d)
Affinity DataIC50: 39nMAssay Description:The method adopted in the test was Caliper Mobility Shift Assay, which was a detection platform based on the mobility detection technology of microfl...More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/13/2023
Entry Details
Go to US Patent

TargetPlatelet-derived growth factor receptor beta(Human)
Wenzhou Medical University

US Patent
LigandPNGBDBM50604036(CHEMBL5190005 | US20230312529, Compound 6h)
Affinity DataIC50: 40nMAssay Description:The method adopted in the test was Caliper Mobility Shift Assay, which was a detection platform based on the mobility detection technology of microfl...More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/13/2023
Entry Details
Go to US Patent

TargetPlatelet-derived growth factor receptor beta(Human)
Wenzhou Medical University

US Patent
LigandPNGBDBM50604036(CHEMBL5190005 | US20230312529, Compound 6h)
Affinity DataIC50: 40nMAssay Description:The method adopted in the test was Caliper Mobility Shift Assay, which was a detection platform based on the mobility detection technology of microfl...More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/13/2023
Entry Details
Go to US Patent

TargetPlatelet-derived growth factor receptor alpha(Human)
Wenzhou Medical University

US Patent
LigandPNGBDBM50604034(CHEMBL5187885 | US20230312529, Compound 6d)
Affinity DataIC50: 46nMAssay Description:The method adopted in the test was Caliper Mobility Shift Assay, which was a detection platform based on the mobility detection technology of microfl...More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/13/2023
Entry Details
Go to US Patent

TargetPlatelet-derived growth factor receptor alpha(Human)
Wenzhou Medical University

US Patent
LigandPNGBDBM50604037(CHEMBL5183593 | US20230312529, Compound 6e)
Affinity DataIC50: 54nMAssay Description:The method adopted in the test was Caliper Mobility Shift Assay, which was a detection platform based on the mobility detection technology of microfl...More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/13/2023
Entry Details
Go to US Patent

TargetPlatelet-derived growth factor receptor alpha(Human)
Wenzhou Medical University

US Patent
LigandPNGBDBM50604037(CHEMBL5183593 | US20230312529, Compound 6e)
Affinity DataIC50: 54nMAssay Description:The method adopted in the test was Caliper Mobility Shift Assay, which was a detection platform based on the mobility detection technology of microfl...More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/13/2023
Entry Details
Go to US Patent

TargetPlatelet-derived growth factor receptor alpha(Human)
Wenzhou Medical University

US Patent
LigandPNGBDBM50604039(CHEMBL5177453 | US20230312529, Compound 6b)
Affinity DataIC50: 55nMAssay Description:The method adopted in the test was Caliper Mobility Shift Assay, which was a detection platform based on the mobility detection technology of microfl...More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/13/2023
Entry Details
Go to US Patent

TargetFibroblast growth factor receptor 2(Human)
Wenzhou Medical University

US Patent
LigandPNGBDBM50604028(CHEMBL5173185 | US20230312529, Compound 6f)
Affinity DataIC50: 61nMAssay Description:The method adopted in the test was Caliper Mobility Shift Assay, which was a detection platform based on the mobility detection technology of microfl...More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/13/2023
Entry Details
Go to US Patent

TargetPlatelet-derived growth factor receptor alpha(Human)
Wenzhou Medical University

US Patent
LigandPNGBDBM50604034(CHEMBL5187885 | US20230312529, Compound 6d)
Affinity DataIC50: 66.6nMAssay Description:The method adopted in the test was Caliper Mobility Shift Assay, which was a detection platform based on the mobility detection technology of microfl...More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/13/2023
Entry Details
Go to US Patent

TargetPlatelet-derived growth factor receptor beta(Human)
Wenzhou Medical University

US Patent
LigandPNGBDBM50604039(CHEMBL5177453 | US20230312529, Compound 6b)
Affinity DataIC50: 68.7nMAssay Description:The method adopted in the test was Caliper Mobility Shift Assay, which was a detection platform based on the mobility detection technology of microfl...More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/13/2023
Entry Details
Go to US Patent

TargetPlatelet-derived growth factor receptor beta(Human)
Wenzhou Medical University

US Patent
LigandPNGBDBM50604034(CHEMBL5187885 | US20230312529, Compound 6d)
Affinity DataIC50: 70.3nMAssay Description:The method adopted in the test was Caliper Mobility Shift Assay, which was a detection platform based on the mobility detection technology of microfl...More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/13/2023
Entry Details
Go to US Patent

TargetPlatelet-derived growth factor receptor beta(Human)
Wenzhou Medical University

US Patent
LigandPNGBDBM50604037(CHEMBL5183593 | US20230312529, Compound 6e)
Affinity DataIC50: 72nMAssay Description:The method adopted in the test was Caliper Mobility Shift Assay, which was a detection platform based on the mobility detection technology of microfl...More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/13/2023
Entry Details
Go to US Patent

Displayed 1 to 50 (of 80 total ) | Next | Last >>
Jump to: